"Clinilabs is a global, full-service CRO dedicated to providing a full range of CNS drug development services to pharmaceutical and biotechnology companies, from first-in-human to Phase 3 trials."

During the past decade, Clinilabs, Inc. conducted 22 clinical trials. In the 10-year time frame, 22 clinical trials started and 21 clinical trials were completed, i.e. on average, 95.5% percent of trials that started reached the finish line to date. In the past 5 years, 10 clinical trials started and 11 clinical trials were completed. i.e. 110% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Clinilabs, Inc." #1 sponsor was "AstraZeneca" with 5 trials, followed by "Eisai Inc." with 3 trials sponsored, "Janssen Research & Development, LLC" with 3 trials sponsored, "Shire" with 3 trials sponsored and "Apnex Medical, Inc." with 3 trials sponsored. Other sponsors include 30 different institutions and companies that sponsored additional 32 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Clinilabs, Inc." #1 collaborator was "Bristol-Myers Squibb" with 1 trials as a collaborator, "Clinilabs, Inc." with 1 trials as a collaborator, "Columbia University" with 1 trials as a collaborator, "Eli Lilly and Company" with 1 trials as a collaborator and "Medpace, Inc." with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "Clinilabs, Inc." are "Obstructive Sleep Apnea" (7 trials), "Insomnia" (5 trials), "Major Depressive Disorder" (3 trials), "Transient Insomnia" (3 trials) and "Alzheimer Disease" (2 trials). Many other conditions were trialed in "Clinilabs, Inc." in a lesser frequency.

Most popular intervention types in "Clinilabs, Inc." are "Drug" (40 trials), "Device" (6 trials), "Other" (3 trials), "Biological" (2 trials) and "Behavioral" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (22 trials), "Armodafinil" (2 trials), "JZP-110" (2 trials), "Metformin XR" (2 trials) and "SM-1" (2 trials). Other intervention names were less common.

The vast majority of trials in "Clinilabs, Inc." are 48 trials for "All" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "Clinilabs, Inc.". 1 are not yet recruiting, 3 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 39 completed trials in Clinilabs, Inc., undefined suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in Clinilabs, Inc., 14 "Phase 1" clinical trials were conducted, 19 "Phase 2" clinical trials and 15 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 4 trials that are defined as “Not Applicable".

Clinilabs, Inc. has several departments that took part in Clinical trials: "Clinilabs / Sleep Disorders In" - 2 trials